{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:38:43Z","timestamp":1787729923301,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejogrb.2025.114531","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T17:46:25Z","timestamp":1750009585000},"page":"114531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Does the use of letrozole in infertility treatment increase the risk of foetal malformations? A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"312","author":[{"given":"Andrea","family":"Etrusco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Agrifoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Simone","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Andrisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Caringella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale De","family":"Franciscis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Riemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114531_b0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin. Biochem."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s43032-021-00829-3","article-title":"The future of IVF: the new normal in human reproduction","volume":"29","author":"Kushnir","year":"2022","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejogrb.2025.114531_b0015","doi-asserted-by":"crossref","unstructured":"European IVF-monitoring Consortium (EIM)\u2021 for the European Society of Human Reproduction and Embryology (ESHRE), Wyns C, Bergh C, Calhaz-Jorge C, De Geyter C, Kupka MS, et al. ART in Europe, 2016: results generated from European registries by ESHRE. Hum Reprod Open. 2020;2020(3):hoaa032.","DOI":"10.1093\/hropen\/hoaa038"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114531_b0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmn033","article-title":"Use of letrozole in assisted reproduction: a systematic review and meta-analysis","volume":"14","author":"Requena","year":"2008","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2025.114531_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S37559","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome","volume":"6","author":"Sirmans","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/biomedicines12030653","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity and treatment with metformin and GLP-1s","volume":"12","author":"Etrusco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejogrb.2025.114531_b0040","doi-asserted-by":"crossref","unstructured":"Franik S, Le Q-K, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2022 Sep;9(9):CD010287.","DOI":"10.1002\/14651858.CD010287.pub4"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114531_b0045","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/humupd\/dmz029","article-title":"First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis","volume":"25","author":"Wang","year":"2019","journal-title":"Hum. Reprod. Update"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114531_b0050","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114531_b0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/humupd\/dmac021","article-title":"Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis","volume":"28","author":"Wessel","year":"2022","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114531_b0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jmig.2020.11.013","article-title":"Hysteroscopy for assessing fallopian tubal obstruction: a systematic review and diagnostic test accuracy meta-analysis","volume":"28","author":"Vitale","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114531_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101763","article-title":"Impact of hysteroscopic metroplasty on reproductive outcomes of women with a dysmorphic uterus and recurrent miscarriages: a systematic review and meta-analysis","volume":"49","author":"De Franciscis","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s13304-020-00712-x","article-title":"Fallopian tubal obstruction is associated with increased pain experienced during office hysteroscopy: a retrospective study","volume":"72","author":"T\u00f6r\u00f6k","year":"2020","journal-title":"Updates Surg."},{"key":"10.1016\/j.ejogrb.2025.114531_b0075","unstructured":"Associazione Italiana di Oncologia Medica (AIOM). Linee guida AIOM 2021: Preservazione della fertilit\u00e0 nei pazienti oncologici. Milan: AIOM; 2021. Available from: https:\/\/www.aiom.it\/linee-guida-aiom-2021-preservazione-della-fertilita-nei-pazienti-oncologici\/."},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2025.114531_b0080","first-page":"S9","article-title":"The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins","volume":"84","author":"Biljan","year":"2005","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114531_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103750","article-title":"Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study","volume":"48","author":"Gallo","year":"2024","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0090","first-page":"353","article-title":"Is the use of letrozole to induce ovulation teratogenic?","volume":"54","author":"Gill","year":"2008","journal-title":"Can. Fam. Physician"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejogrb.2025.114531_b0100","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019 Oct;10:ED000142.","DOI":"10.1002\/14651858.ED000142"},{"key":"10.1016\/j.ejogrb.2025.114531_b0105","article-title":"Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome. Pak","volume":"40(1Part-I):78\u201383","author":"Wasim","year":"2024","journal-title":"J. Med. Sci."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12905-023-02773-7","article-title":"Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial","volume":"23","author":"Chera-Aree","year":"2023","journal-title":"BMC Womens Health"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114531_b0115","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018383","article-title":"Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: a randomized controlled study","volume":"99","author":"Shi","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114531_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","article-title":"Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial","volume":"33","author":"Liu","year":"2017","journal-title":"Gynecol. Endocrinol."},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114531_b0130","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer","year":"2017","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114531_b0135","first-page":"83","article-title":"Can letrozole plus HMG protocol improve pregnancy outcomes in frozen-thawed embryo transfer?","volume":"15","author":"Aleyasin","year":"2017","journal-title":"An RCT Int J Reprod Biomed"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114531_b0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijgo.2015.06.063","article-title":"A randomized controlled trial of clomifene citrate, metformin, and pioglitazone versus letrozole, metformin, and pioglitazone for clomifene-citrate-resistant polycystic ovary syndrome","volume":"132","author":"El-khayat","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"13","key":"10.1016\/j.ejogrb.2025.114531_b0145","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1414827","article-title":"Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility","volume":"373","author":"Diamond","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114531_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0974-1208.97789","article-title":"A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome","volume":"5","author":"Roy","year":"2012","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0160","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00404-011-2091-7","article-title":"Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction in Indian women with polycystic ovarian syndrome","volume":"285","author":"Banerjee Ray","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ejogrb.2025.114531_b0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1477-7827-9-84","article-title":"Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial","volume":"9","author":"Fouda","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0412.2011.01346.x","article-title":"Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis","volume":"91","author":"Abu Hashim","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0175","first-page":"29","article-title":"Comparing of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles","volume":"10","author":"Akbari","year":"2012","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114531_b0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00016340802638199","article-title":"Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility","volume":"88","author":"Badawy","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114531_b0185","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/humrep\/del020","article-title":"Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease","volume":"21","author":"Sohrabvand","year":"2006","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114531_b0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2005.09.045","article-title":"Letrozole vs. clomiphene citrate in patients with ovulatory infertility","volume":"85","author":"Bayar","year":"2006","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0195","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.fertnstert.2016.05.022","article-title":"Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome","volume":"106","author":"Wu","year":"2016","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijgo.2010.11.026","article-title":"Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome","volume":"113","author":"Abdellah","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ejogrb.2025.114531_b0205","first-page":"1077","article-title":"Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective","volume":"9","author":"He","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"19","key":"10.1016\/j.ejogrb.2025.114531_b0210","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3\u20135","key":"10.1016\/j.ejogrb.2025.114531_b0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0960-0760(03)00358-3","article-title":"Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice","volume":"86","author":"Luthra","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1\u20135","key":"10.1016\/j.ejogrb.2025.114531_b0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0960-0760(01)00133-9","article-title":"Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology","volume":"79","author":"Mandava","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejogrb.2025.114531_b0225","unstructured":"Agenzia Italiana del Farmaco (AIFA). Determina n. 111\/2023: Linee guida per l\u2019uso dei farmaci. Rome: AIFA; 2023. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/241044\/111.90800.11388008926765b96.pdf."},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0230","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humupd\/dmaa055","article-title":"Risk of foetal harm with letrozole use in fertility treatment: a systematic review and meta-analysis","volume":"27","author":"Pundir","year":"2021","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114531_b0235","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biom14030306","article-title":"Reproductive and oncologic outcomes in young women with stage IA and grade 2 endometrial carcinoma undergoing fertility-sparing treatment: a systematic review","volume":"14","author":"Etrusco","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114531_b0240","article-title":"Reproductive outcomes in women with BRCA 1\/2 germline mutations: a retrospective observational study and literature review","volume":"19","author":"Dellino","year":"2024","journal-title":"Open Med (Wars)"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525008073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525008073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:28:22Z","timestamp":1753453702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525008073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S0301211525008073"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114531","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does the use of letrozole in infertility treatment increase the risk of foetal malformations? A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114531"}}